Alexandre Belot

Groupement Hospitalier Est
Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 290 publications

HSCT in SAVI: evidence for a curative hematopoietic approach and perspectives for gene therapy.

HSCT in SAVI: evidence for a curative hematopoietic approach and perspectives for gene therapy.

Journal: Molecular therapy. Advances

Published: July 09, 2026

SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children: A Case-Control Study.

SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children: A Case-Control Study.

Journal: The Pediatric infectious disease journal

Published: May 20, 2026

Neutralizing autoantibodies against IL-1Ra in severe bacterial community-acquired pneumonia.

Neutralizing autoantibodies against IL-1Ra in severe bacterial community-acquired pneumonia.

Journal: The Journal of allergy and clinical immunology

Published: April 28, 2026

Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases.

Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases.

Journal: La Revue de medecine interne

Published: April 08, 2026

PDE4 inhibitor mitigates activated CD8+ T cells through NF-κB signaling in Behçet's syndrome.

PDE4 inhibitor mitigates activated CD8+ T cells through NF-κB signaling in Behçet's syndrome.

Journal: Frontiers in immunology

Published: March 19, 2026

Early and transient expansion of TCR Vβ21.3+ T cells in children with MIS-C: Clinical and longitudinal immunological characterization.

Early and transient expansion of TCR Vβ21.3+ T cells in children with MIS-C: Clinical and longitudinal immunological characterization.

Journal: Joint bone spine

Published: March 15, 2026

A novel STAT4 gain-of-function variant defines a monogenic form of juvenile-onset systemic lupus erythematosus.

A novel STAT4 gain-of-function variant defines a monogenic form of juvenile-onset systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases

Published: February 21, 2026

Anifrolumab, a potential treatment for ADA2 deficiency.

Anifrolumab, a potential treatment for ADA2 deficiency.

Journal: RMD open

Published: January 04, 2026

Childhood-onset hypocomplementaemic urticarial vasculitis in France: phenotypic and genotypic diversity in 10 children.

Childhood-onset hypocomplementaemic urticarial vasculitis in France: phenotypic and genotypic diversity in 10 children.

Journal: Pediatric rheumatology online journal

Published: December 22, 2025

Belimumab use in paediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive study.

Belimumab use in paediatric-onset systemic lupus erythematosus: a status report in France from a retrospective multicentre descriptive study.

Journal: Rheumatology (Oxford, England)

Published: November 09, 2025

Pharmacological stabilization of hypoxia-inducible factor 1-α dampens the interferon response and promotes glycolysis in Aicardi-Goutières syndrome.

Pharmacological stabilization of hypoxia-inducible factor 1-α dampens the interferon response and promotes glycolysis in Aicardi-Goutières syndrome.

Journal: Nature communications

Published: November 04, 2025

Improving care for children with juvenile idiopathic arthritis: the role of IL-6 inhibitors in a patient-centered approach.

Improving care for children with juvenile idiopathic arthritis: the role of IL-6 inhibitors in a patient-centered approach.

Journal: Expert opinion on biological therapy

Published: October 18, 2025

Showing 1-12 of 290

Last Updated: 09/26/2026